Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
825.00    0.00 (0.00%)
Bid:
815.00
Ask:
845.00
Spread: 30.00 (3.681%)
Market Cap: £134.64m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

Share Purchase

29 Mar 2016 15:58

RNS Number : 4412T
Arbuthnot Banking Group PLC
29 March 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Arbuthnot Banking Group

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Slater Investments Ltd

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

24th March 2016

6. Date on which issuer notified:

29th March 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

Above 3%

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0007922338

291,391

 

291,391

 

0

0

466,391

0%

3.05%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

466,391

3.05%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14. Contact name:

J.R. Kaye

15. Contact telephone number:

020 7012 2430

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUKVSRNOAOUAR
Date   Source Headline
1st Jun 20267:00 amRNSAdmission of Non-Voting Shares to Trading on AIM
20th May 20267:00 amRNSAppointment of New Non-Executive Director
19th May 20263:45 pmRNSResult of AGM
19th May 20262:34 pmRNSAnnual General Meeting 2026 & Trading Update
26th Mar 20263:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSAudited Final Results for the year to 31/12/2025
11th Mar 20262:34 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSPre Close Trading Update
23rd Oct 20257:00 amRNSThird Quarter 2025 Trading Update
22nd Jul 20257:00 amRNSUnaudited results for the six months to 30/06/2025
8th Jul 20257:00 amRNSAppointment of independent non-executive director
21st May 20253:40 pmRNSResult of AGM
21st May 20252:19 pmRNS2025 AGM Trading Update
27th Mar 20257:00 amRNSAudited Final Results for the year ended 31/12/24
20th Feb 20257:00 amRNSPre-Close Trading Update
25th Nov 20242:31 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
12th Aug 20248:59 amRNSChange of Registered Office
23rd Jul 20247:00 amRNSUnaudited results for the six months to 30/06/2024
2nd Jul 20249:41 amRNSAppointment of Independent Non-Executive Director
5th Jun 20243:35 pmRNSHolding(s) in Company
4th Jun 202412:02 pmRNSCompletion of Tier 2 Reg. Cap. Facility Renewal
30th May 20247:00 amRNSNotification of Special and Interim Dividends
22nd May 20243:41 pmRNSResult of AGM
22nd May 20247:00 amRNSAnnual General Meeting 2024 Trading Update
22nd Apr 20243:49 pmEQSQ&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends
8th Apr 20243:50 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB): 2023 - delivering strategy with strong profit growth
28th Mar 20247:00 amRNSAudited Final Results
21st Feb 20247:00 amRNSPre Close Trading Update
8th Feb 20241:57 pmRNSDirector/PDMR Shareholding
19th Dec 20232:06 pmRNSRenewal of Tier 2 Regulatory Capital Loan facility
5th Dec 202312:47 pmRNSDirector/PDMR Shareholding
13th Nov 20233:40 pmEQSHardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’
30th Oct 202310:34 amRNSDirector/PDMR Shareholding
26th Oct 202310:05 amRNSDirector/PDMR Shareholding
24th Oct 20233:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) Trading update: taking ABG to the next level
19th Oct 20237:00 amRNSThird Quarter 2023 Trading Update
22nd Aug 20237:00 amRNSAppointment of New Directors
4th Aug 202311:15 amEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 1H’23: steering through the interest rate wave
18th Jul 20237:00 amRNSUnaudited results for the 6 months to 30 June 2023
31st May 202312:37 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
24th May 20233:23 pmRNSAnnual General Meeting Result - 2023
24th May 20237:00 amRNSAnnual General Meeting 2023 Trading Update
5th May 20233:27 pmRNSHolding(s) in Company
5th May 20238:05 amRNSDirector/PDMR Shareholding
4th May 202311:32 amRNSResult of General Meeting and Total Voting Rights
3rd May 20231:45 pmEQSHardman & Co Q&A on Arbuthnot Banking Group (ARBB): Core and new franchises growth in profits and loans
14th Apr 20235:30 pmRNSPlacing and Subscription raising £12.0 million
6th Apr 202312:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 2022: profits and growth in core and new franchises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.